|
|
|
|
|
|
|
08.01.26 - 13:03
|
Bruker Consolidates Ownership of TOFWERK in Expansion of Mass Spectrometry Portfolio into New Applied Markets (Business Wire)
|
|
|
TOFWERK is a profitable innovator in compact, ultra-fast time-of-flight (TOF) mass spectrometry for real-time air and semiconductor cleanroom monitoring, food, flavors & fragrances markets, and FIB-TOF accessories for electron microscopes
The ultra-sensitive Vocus™ TOF-MS is customizable for real-time air and cleanroom monitoring applications
Microwave-induced plasma (MIP)-TOF systems with atto-to-femtogram detection limits for real-time quantification of trace elements and metals
Proprietary flow tube-based VUV CI sources for positive and negative trace organics, inorganics and PFAS contaminants
Focused Ion Beam (FIB)-TOF accessories for scanning electron microscopes
THUN, Switzerland--(BUSINESS WIRE)--$BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of an additional 60% ownership stake in TOFWERK AG, a Switzerland-based innovator in ultra-fast time-of-flight (TOF) mass spectrometry technology for small molecule applied markets, consolidating Bruker's ownership to 100%. T...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
08.12.25 - 14:03
|
Bruker Announces the Addition of Diagnostics Industry Leader Jack Phillips to its Board of Directors as of January 2026 (Business Wire)
|
|
|
BILLERICA, Mass.--(BUSINESS WIRE)--$BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has added Jack J. Phillips to serve on its board of directors, effective as of January 1st, 2026. Mr. Phillips is a senior healthcare industry executive with over 30 years of leadership experience in the diagnostics industry.
Frank H. Laukien, chairman, president and CEO of Bruker Corporation, stated: “Bruker is delighted to add Jack to our board of directors. His broad and deep diagnostics experience, strategic acumen and market development experience will be very valuable to Bruker and our board. I admire Jack's proven ability to translate scientific innovations into clinical impact for patient benefit and to accelerate profitable business growth in diagnostics. Jack's addition to our board is timely, as we broaden our infectious disease diagnostics portfolio, and increasingly leverage our unique disease biology research tools for opportunities in specialty diagnostics.”
Ja...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
04.11.25 - 22:03
|
Bruker Announces Quarterly Common Stock Dividend and Preferred Stock Dividend (Business Wire)
|
|
|
BILLERICA, Mass.--(BUSINESS WIRE)--$BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR, BRKRP) today announced that its Board of Directors (“Board”) has approved payment of a quarterly cash dividend in the amount of $0.05 per share on the Company's common stock, par value $0.01 per share (the “Common Stock Dividend”). The Common Stock Dividend will be paid on January 2, 2026 to stockholders of record as of December 8, 2025.
The Board also approved payment of a quarterly cash dividend in the amount of $3.6745 per share on the Company's 6.375% Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share (the “Mandatory Convertible Preferred Stock Dividend”). The Mandatory Convertible Preferred Stock Dividend will be paid on December 1, 2025 to stockholders of record as of November 15, 2025.
About Bruker Corporation – Leader of the Post-Genomic Era
Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop new applications that improve the qu...
|
|
|
|
|
04.11.25 - 01:00
|
Bruker Shares Rise After Q3 Earnings Beat, but Guidance Is Cautious (24/7 Wall St.)
|
|
|
Bruker Corporation (NASDAQ: BRKR) delivered a sharp earnings beat this morning, lifting shares nearly 7% despite underlying headwinds that reveal a company in transition. Non-GAAP EPS of $0.45 crushed the $0.34 consensus estimate by 32%, but the real story sits beneath the headline: organic revenue is contracting, margins are compressing and restructuring charges are masking ... Bruker Shares Rise After Q3 Earnings Beat, but Guidance Is Cautious
The post Bruker Shares Rise After Q3 Earnings Beat, but Guidance Is Cautious appeared first on 24/7 Wall St.....
|
|